Lenalidomide and disease progression Patient Reports February 11, 2012

Lenalidomide Side Effects Report #5369910-5
Lenalidomide side effect was reported by a Physician from NETHERLANDS on June 13, 2007. Male patient, 56 years of age, weighting 132.3 lb, was diagnosed with multiple myeloma  and was treated with Lenalidomide. After drug was administered, patient experienced the following side effects: disease progression, malignant neoplasm progression, multiple myeloma , pain , pyrexia, renal impairment. Lenalidomide dosage: 25 MG, 1 IN 1 D; ORAL. During the same period patient was treated with MORPHINE. Patient died.

Lenalidomide Side Effects Report #5951441-2
Lenalidomide side effect was reported by a Consumer or non-health professional from UNITED STATES on Nov 11, 2008. Female patient, weighting 97.00 lb, was diagnosed with hodgkin's disease  and was treated with Lenalidomide. After drug was administered, patient experienced the following side effects: asthenia, dehydration, disease progression, dysphagia, lymphadenopathy. Lenalidomide dosage: 25 MG Q DAY. During the same period patient was treated with ASPIRIN, FUROSEMIDE, BISACODYL, POTASSIUM CHLORIDE. Patient was hospitalized. Patient recovered.

Lenalidomide Side Effects Report #6125354-X
Lenalidomide side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 19, 2009. Male patient, weighting 147.3 lb, was diagnosed with hodgkin's disease  and was treated with Lenalidomide. After drug was administered, patient experienced the following side effects: cough, disease progression, haemoglobin decreased, pyrexia, vomiting. Lenalidomide dosage: 25 MG/DAY PO. During the same period patient was treated with VALTREX, OXYCODONE. Patient was hospitalized. Patient recovered.

Lenalidomide Side Effects Report #5943343-2
Lenalidomide side effect was reported by a Health Professional from UNITED STATES on Nov 05, 2008. Male patient, 77 years of age, weighting 147.0 lb, was diagnosed with hepatic neoplasm malignant and was treated with Lenalidomide. After drug was administered, patient experienced the following side effects: abdominal distension, alpha 1 foetoprotein increased, asthenia, blister, cellulitis , confusional state, cough, disease progression, erythema. Lenalidomide dosage: 25 MG DAILY X 21 DAYS PO. During the same period patient was treated with FURESOMIDE, ALDACTONE, PREDNISONE, COMPAZINE, NORVASC, LISINOPRIL, ETANERCEPT, CELEBREX. Patient was hospitalized. Patient recovered.